Aurora Private Wealth Inc. Takes $1.70 Million Position in Koninklijke Philips N.V. (NYSE:PHG)

Aurora Private Wealth Inc. bought a new stake in Koninklijke Philips N.V. (NYSE:PHG - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 66,726 shares of the technology company's stock, valued at approximately $1,695,000.

Several other large investors have also made changes to their positions in the business. Sequoia Financial Advisors LLC boosted its holdings in shares of Koninklijke Philips by 4.5% in the 4th quarter. Sequoia Financial Advisors LLC now owns 8,932 shares of the technology company's stock valued at $226,000 after acquiring an additional 384 shares during the last quarter. Dorsey & Whitney Trust CO LLC boosted its holdings in Koninklijke Philips by 3.9% in the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 11,401 shares of the technology company's stock valued at $289,000 after purchasing an additional 427 shares during the last quarter. Farther Finance Advisors LLC boosted its holdings in Koninklijke Philips by 37.1% in the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company's stock valued at $54,000 after purchasing an additional 582 shares during the last quarter. Pzena Investment Management LLC boosted its holdings in Koninklijke Philips by 5.1% in the fourth quarter. Pzena Investment Management LLC now owns 13,683 shares of the technology company's stock valued at $346,000 after purchasing an additional 670 shares during the last quarter. Finally, Atria Investments Inc boosted its holdings in Koninklijke Philips by 4.1% in the fourth quarter. Atria Investments Inc now owns 19,009 shares of the technology company's stock valued at $481,000 after purchasing an additional 741 shares during the last quarter. 13.67% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Sanford C. Bernstein upgraded Koninklijke Philips from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, March 18th. Wall Street Zen lowered Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Sunday, June 15th. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Koninklijke Philips has a consensus rating of "Moderate Buy".

Koninklijke Philips Stock Performance

NYSE PHG traded down $0.35 during mid-day trading on Friday, reaching $24.17. 871,452 shares of the stock were exchanged, compared to its average volume of 899,039. The business's 50 day moving average is $23.71 and its 200-day moving average is $25.01. Koninklijke Philips N.V. has a 1 year low of $20.61 and a 1 year high of $31.57. The company has a market capitalization of $23.27 billion, a P/E ratio of 56.21, a P/E/G ratio of 0.68 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.79 and a current ratio of 1.28.

Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its earnings results on Tuesday, May 6th. The technology company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.13. Koninklijke Philips had a net margin of 2.11% and a return on equity of 10.97%. The business had revenue of $4.31 billion for the quarter, compared to analyst estimates of $4.10 billion. During the same period in the prior year, the company posted $0.21 EPS. The company's revenue for the quarter was down 1.0% on a year-over-year basis. On average, equities research analysts forecast that Koninklijke Philips N.V. will post 1.63 EPS for the current fiscal year.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.